Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jun 2

PMID 34070493

Citations 5

Authors

Mohammad Jalili-Nik

Farzaneh Abbasinezhad-Moud

Sajad Sahab-Negah

Abolfazl Maghrouni

Mohammad Etezad Razavi

Maryam Khaleghi Ghadiri

Walter Stummer

Ali Gorji

Affiliations

Soon will be listed here.

Abstract

5-Aminolevulinic acid (5-ALA) is a naturally occurring non-proteinogenic amino acid, which contributes to the diagnosis and therapeutic approaches of various cancers, including glioblastoma (GBM). In the present study, we aimed to investigate whether 5-ALA exerted cytotoxic effects on GBM cells. We assessed cell viability, apoptosis rate, mRNA expressions of various apoptosis-related genes, generation of reactive oxygen species (ROS), and migration ability of the human U-87 malignant GBM cell line (U87MG) treated with 5-ALA at different doses. The half-maximal inhibitory concentration of 5-ALA on U87MG cells was 500 μg/mL after 7 days; 5-ALA was not toxic for human optic cells and NIH-3T3 cells at this concentration. The application of 5-ALA led to a significant increase in apoptotic cells, enhancement of Bax and p53 expressions, reduction in Bcl-2 expression, and an increase in ROS generation. Furthermore, the application of 5-ALA increased the accumulation of U87MG cells in the SUB-G1 population, decreased the expression of cyclin D1, and reduced the migration ability of U87MG cells. Our data indicate the potential cytotoxic effects of 5-ALA on U87MG cells. Further studies are required to determine the spectrum of the antitumor activity of 5-ALA on GBM.

Citing Articles

Effect of combined blue light and 5-ALA on mitochondrial functions and cellular responses in B16F1 melanoma and HaCaT cells.

Sato K, Sato T, Hirotani R, Bam M Cytotechnology. 2024; 76(6):795-816.

PMID: 39435424 PMC: 11490642. DOI: 10.1007/s10616-024-00654-x.

In Vitro Sonodynamic Therapy Using a High Throughput 3D Glioblastoma Spheroid Model with 5-ALA and TMZ Sonosensitizers.

Datta P, Lee N, Moolayadukkam S, Sahu R, Yu X, Guo T Adv Healthc Mater. 2024; 13(32):e2402877.

PMID: 39434433 PMC: 11670275. DOI: 10.1002/adhm.202402877.

The protective effect of parthenolide in an in vitro model of Parkinson's disease through its regulation of nuclear factor-kappa B and oxidative stress.

Shariat Razavi S, Vafaei F, Ebrahimi S, Abbasinezhad-Moud F, Shahini A, Qoorchi Moheb Seraj F Mol Biol Rep. 2024; 51(1):819.

PMID: 39017801 DOI: 10.1007/s11033-024-09779-w.

Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line.

Meybodi S, Moraddahande F, Dehghani Firoozabadi A Heliyon. 2024; 10(9):e29858.

PMID: 38698968 PMC: 11064142. DOI: 10.1016/j.heliyon.2024.e29858.

Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma.

Gousias K, Theocharous T, Simon M Biomedicines. 2022; 10(3).

PMID: 35327366 PMC: 8945784. DOI: 10.3390/biomedicines10030564.

References

Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C . Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998; 42(3):518-25; discussion 525-6. DOI: 10.1097/00006123-199803000-00017. View

Han S, Englot D, Birk H, Molinaro A, Chang S, Clarke J . Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence. Neurosurgery. 2015; 62 Suppl 1:160-5. PMC: 5260825. DOI: 10.1227/NEU.0000000000000801. View

Yang X, Palasuberniam P, Myers K, Wang C, Chen B . Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response. Oncotarget. 2016; 7(36):57798-57810. PMC: 5295390. DOI: 10.18632/oncotarget.11058. View

Castro-Gamero A, Pezuk J, Brassesco M, Tone L . G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future. Cancer Biol Med. 2019; 15(4):354-374. PMC: 6372908. DOI: 10.20892/j.issn.2095-3941.2018.0030. View

Chen J . The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression. Cold Spring Harb Perspect Med. 2016; 6(3):a026104. PMC: 4772082. DOI: 10.1101/cshperspect.a026104. View

Luwor R, Morokoff A, Amiridis S, DAbaco G, Paradiso L, Stylli S . Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma. Cancer Invest. 2019; 37(3):144-155. DOI: 10.1080/07357907.2019.1582060. View

Nakayama T, Otsuka S, Kobayashi T, Okajima H, Matsumoto K, Hagiya Y . Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy. Sci Rep. 2016; 6:36478. PMC: 5114660. DOI: 10.1038/srep36478. View

Miyake M, Tanaka N, Hori S, Ohnishi S, Takahashi H, Fujii T . Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model. Prostate. 2018; 79(4):340-351. DOI: 10.1002/pros.23740. View

Yamamoto J, Ogura S, Shimajiri S, Nakano Y, Akiba D, Kitagawa T . 5-aminolevulinic acid-induced protoporphyrin IX with multi-dose ionizing irradiation enhances host antitumor response and strongly inhibits tumor growth in experimental glioma in vivo. Mol Med Rep. 2014; 11(3):1813-9. DOI: 10.3892/mmr.2014.2991. View

10.

Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V . Research Techniques Made Simple: Analysis of Collective Cell Migration Using the Wound Healing Assay. J Invest Dermatol. 2017; 137(2):e11-e16. DOI: 10.1016/j.jid.2016.11.020. View

11.

Koeller H, Ross M, Glickstein S . Cyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity. Neurobiol Dis. 2008; 31(2):230-41. PMC: 2614463. DOI: 10.1016/j.nbd.2008.04.010. View

12.

Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S . Survival Analysis of Glioblastoma Multiforme. Asian Pac J Cancer Prev. 2018; 19(9):2613-2617. PMC: 6249474. DOI: 10.22034/APJCP.2018.19.9.2613. View

13.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

14.

Akbarnejad Z, Eskandary H, Dini L, Vergallo C, Nematollahi-Mahani S, Farsinejad A . Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G). Biomed Pharmacother. 2017; 92:254-264. DOI: 10.1016/j.biopha.2017.05.050. View

15.

Cemeli T, Guasch-Valles M, Nager M, Felip I, Cambray S, Santacana M . Cytoplasmic cyclin D1 regulates glioblastoma dissemination. J Pathol. 2019; 248(4):501-513. DOI: 10.1002/path.5277. View

16.

Fels C, Schafer C, Huppe B, Bahn H, Heidecke V, Kramm C . Bcl-2 expression in higher-grade human glioma: a clinical and experimental study. J Neurooncol. 2000; 48(3):207-16. DOI: 10.1023/a:1006484801654. View

17.

Yang P, Hernandez M . Purification of astrocytes from adult human optic nerve heads by immunopanning. Brain Res Brain Res Protoc. 2003; 12(2):67-76. DOI: 10.1016/s1385-299x(03)00073-4. View

18.

Chen X, Zhao P, Chen F, Li L, Luo R . Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer. Lasers Med Sci. 2010; 26(1):69-78. DOI: 10.1007/s10103-010-0810-0. View

19.

Eisele G, Weller M . Targeting apoptosis pathways in glioblastoma. Cancer Lett. 2011; 332(2):335-45. DOI: 10.1016/j.canlet.2010.12.012. View

20.

Suehiro S, Ohnishi T, Yamashita D, Kohno S, Inoue A, Nishikawa M . Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model. J Neurosurg. 2018; 129(6):1416-1428. DOI: 10.3171/2017.6.JNS162398. View